Tamoxifen (TAM), a nonsteroidal antiestrogen drug, is the most-prescribed selective estrogen receptor modulator2 used to treat luminal A breast cancer patients, and it decreases mortality rate to 31%3. The gene discussed is ESR1; the disease is breast cancer.